Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,548,006
-$1,137,621 QoQ
Shares Held
64,286
-32.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#1,079
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Berkeley Capital Partners, LLC holds $14,092,981 across 9 Drug Manufacturers - General names. PFE ranks #6 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
12,370 | $3,141,608 | |
| 2 | MRK |
Merck & Co., Inc.
|
17,441 | $2,241,168 | |
| 3 | ABBV |
AbbVie Inc.
|
7,720 | $1,942,660 | |
| 4 | LLY |
ELI LILLY & Co
|
1,361 | $1,632,424 | |
| 5 | NVS |
Novartis AG
|
10,041 | $1,573,625 | |
| 6 | PFE |
Pfizer Inc
This page
|
64,286 | $1,548,006 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
25,331 | $1,459,572 | |
| 8 | NVO |
Novo Nordisk A S
|
6,115 | $293,153 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,548,006 | 64,286 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,685,627 | 95,642 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,817,426 | 72,989 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,844,955 | 72,408 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,837,682 | 75,812 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,825,594 | 72,044 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,835,610 | 69,190 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,958,051 | 67,659 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,832,410 | 65,490 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,788,709 | 64,458 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $903,516 | 31,383 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,054,009 | 31,776 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,178,014 | 32,116 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,309,598 | 32,098 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,190,458 | 42,749 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,890,169 | 43,194 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $2,241,487 | 42,752 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,181,950 | 42,147 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $2,477,974 | 41,964 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,938,202 | 45,064 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $1,792,157 | 45,765 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,664,949 | 45,955 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,683,542 | 45,736 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $1,765,818 | 48,115 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,768,548 | 54,084 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $1,986,859 | 60,872 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||